BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19223407)

  • 21. No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure.
    Dass S; Holloway CJ; Cochlin LE; Rider OJ; Mahmod M; Robson M; Sever E; Clarke K; Watkins H; Ashrafian H; Karamitsos TD; Neubauer S
    Circ Heart Fail; 2015 Nov; 8(6):1088-93. PubMed ID: 26333351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease.
    Stuijfzand WJ; Uusitalo V; Kero T; Danad I; Rijnierse MT; Saraste A; Raijmakers PG; Lammertsma AA; Harms HJ; Heymans MW; Huisman MC; Marques KM; Kajander SA; Pietilä M; Sörensen J; van Royen N; Knuuti J; Knaapen P
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25596142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial perfusion reserve compared with peripheral perfusion reserve: a [13N]ammonia PET study.
    Scholtens AM; Tio RA; Willemsen A; Dierckx RA; Boersma HH; Zeebregts CJ; Glaudemans AW; Slart RH
    J Nucl Cardiol; 2011 Apr; 18(2):238-46. PubMed ID: 21347555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.
    Ohshima S; Isobe S; Izawa H; Nanasato M; Ando A; Yamada A; Yamada K; Kato TS; Obata K; Noda A; Nishizawa T; Kato K; Nagata K; Okumura K; Murohara T; Yokota M
    J Am Coll Cardiol; 2005 Dec; 46(11):2061-8. PubMed ID: 16325043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy.
    Tansley P; Yacoub M; Rimoldi O; Birks E; Hardy J; Hipkin M; Bowles C; Kindler H; Dutka D; Camici PG
    J Heart Lung Transplant; 2004 Nov; 23(11):1283-9. PubMed ID: 15539127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study.
    Danad I; Raijmakers PG; Harms HJ; Heymans MW; van Royen N; Lubberink M; Boellaard R; van Rossum AC; Lammertsma AA; Knaapen P
    Eur Heart J; 2014 Aug; 35(31):2094-105. PubMed ID: 24780500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy.
    Drzezga AE; Blasini R; Ziegler SI; Bengel FM; Picker W; Schwaiger M
    J Nucl Med; 2000 May; 41(5):837-44. PubMed ID: 10809200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT.
    Miller WL; Behrenbeck TR; McCollough CH; Williamson EE; Leng S; Kline TL; Ritman EL
    Int J Cardiovasc Imaging; 2015 Apr; 31(4):881-8. PubMed ID: 25712168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography.
    Karamitsos TD; Leccisotti L; Arnold JR; Recio-Mayoral A; Bhamra-Ariza P; Howells RK; Searle N; Robson MD; Rimoldi OE; Camici PG; Neubauer S; Selvanayagam JB
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 19920032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and echocardiographic features in patients with dilated cardiomyopathy: wave intensity and diastolic abnormality analysis.
    Siniawski H; Unbehaun A; Lehmkuhl H; Susanne K; Schoen F; Hetzer R
    Przegl Lek; 2002; 59(8):562-7. PubMed ID: 12638320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy.
    Lezaic L; Socan A; Poglajen G; Peitl PK; Sever M; Cukjati M; Cernelc P; Wu JC; Haddad F; Vrtovec B
    J Card Fail; 2015 Feb; 21(2):145-52. PubMed ID: 25459687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy.
    Bell SP; Adkisson DW; Ooi H; Sawyer DB; Lawson MA; Kronenberg MW
    J Card Fail; 2013 Dec; 19(12):802-10. PubMed ID: 24331202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of endothelial function and myocardial flow reserve using (15)O-water PET without attenuation correction.
    Tuffier S; Legallois D; Belin A; Joubert M; Bailliez A; Redonnet M; Agostini D; Manrique A
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):288-295. PubMed ID: 26280980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus.
    Watzinger N; Lund GK; Saeed M; Reddy GP; Araoz PA; Yang M; Schwartz AB; Bedigian M; Higgins CB
    J Magn Reson Imaging; 2005 Apr; 21(4):347-53. PubMed ID: 15778950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and echocardiographic evaluation of the effects of atrial defibrillation in patients with idiopathic cardiomyopathy].
    Shite J; Yokota Y; Nakatani M; Takeuchi Y; Tsumura Y; Kawai H; Ueno H; Kawashima T; Honda Y
    J Cardiol; 1992; 22(1):73-82. PubMed ID: 1307580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy.
    Weismüller S; Czernin J; Sun KT; Fung C; Phelps ME; Schelbert HR
    Am J Card Imaging; 1996 Jul; 10(3):154-62. PubMed ID: 8914701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of type 2 diabetes mellitus with the development of new-onset atrial fibrillation in patients with non-ischemic dilated cardiomyopathy: impact of SGLT2 inhibitors.
    Tanaka H; Tatsumi K; Matsuzoe H; Soga F; Matsumoto K; Hirata KI
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1333-1341. PubMed ID: 33392879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation.
    Smit MD; Tio RA; Slart RH; Zijlstra F; Van Gelder IC
    Europace; 2010 May; 12(5):643-8. PubMed ID: 20022875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.